PatientsVille.com Logo

WHITE BLOOD CELL COUNT DECREASED and Diazepam

PatientsVille

WHITE BLOOD CELL COUNT DECREASED Symptoms and Causes

We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.

Check out the latest treatments for WHITE BLOOD CELL COUNT DECREASED

WHITE BLOOD CELL COUNT DECREASED treatment research studies

Diazepam clinical trials, surveys and public health registries


Find Drug Side Effect reports



Diazepam Side Effects

Toxicity To Various Agents (570)
Completed Suicide (509)
Cardiac Arrest (440)
Respiratory Arrest (434)
Poisoning (391)
Death (378)
Overdose (157)
Cardio-respiratory Arrest (152)
Exposure Via Ingestion (127)
Anxiety (81)
Suicide Attempt (75)
Intentional Overdose (73)
Somnolence (72)
Hypotension (71)
Loss Of Consciousness (63)
Confusional State (61)
Dizziness (58)
Tachycardia (57)
Vomiting (53)
Headache (52)
Agitation (50)
Convulsion (50)
Respiratory Depression (48)
Fall (48)
Pyrexia (47)
Malaise (46)
Pulmonary Oedema (46)
Depression (45)
Coma (44)
Dyspnoea (43)
Insomnia (41)
Nausea (40)
Feeling Abnormal (38)
Therapeutic Agent Toxicity (37)
Sedation (37)
Poisoning Deliberate (37)
Pain (37)
Aggression (34)
Sopor (34)
Serotonin Syndrome (31)
Dysarthria (31)
Neuroleptic Malignant Syndrome (30)
Disorientation (30)
Fatigue (29)
Accidental Overdose (28)
Delirium (28)
Pneumonia (28)
Depressed Level Of Consciousness (28)
Hypertension (28)
Hallucination (27)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Anon- I would say the weed would cause the MOST memory loss used over time also depending on how strong it is ie, (haze, kush....dro...regs from 60's with seeds) THE STONGER it is the faster the brain cells go! As far as the valium/dia

I find that taking diazepam 5mg twice a day i get totally relaxed and sleep well.My coordination would not be the bestso i do avoid driving.The only problem i seem to be having regarding it is that i needto take it every day or i become agi

I have had a very similar experience however I have terrifying and vivid nightmares the following night after a sound nights sleep has already been had. Most of the dreams end with me thinking that I have woken up and that I am having horrible halluc

I take 50 diazepam 5 m tab what is the side effect?

My daughter has taken diasepam25mg for many years.could this cause longterm memory loss?she also takes 85mg methedone also smokes weed.which of them would cause the memory loss most?

My doctor prescribed valium for stress and anxiety. I have had very strange and lucid dreams. I am also taking antibiotics, lovenox,and nadalol, for some serious medical conditions. *DONT_KNOW*

I've been taking Coversyl for almost two weeks now. My doctor prescribed it when the Natrilix I had been taking for a couple of months wasn't bringing my blood pressure down fast enough. The only side effects I've noticed since commencing the C

Marax was the asthma the best medicine for me to treat asthma. Inhalers do not work. Apparently centuries of using the contents of Marax with success does not count with the FDA. Shame on them. Bring back this medication.

<span style='text-decoration: underline; text-underline: single;'>How it stop you getting haemophilia<span style='mso-spacerun: yes;'> or sickle cell?

As mentioned in many reviews i have read I experienced the first 2 months with lots of purging white heads etc. Now my skin is clear and smooth with scars clearing rapidly. Over the last 3 weeks i am experiencing nausea and headaches mild to heav

Does panadeine increase blood pressure?

I HAD 1 SHOT OF THIS AND WITHIN 12 HOURS I WENT FROM A VERY NORMAL BLOOD PRESSURE TO WAKING AT 5 A.M. NEXT DAY WITH 198/110 AND 104 PULSE RATE. IT HAS CONTINUED ALL WEEK AFTER AND I'M NOW ON A BLOOD PRESSURE DRUG TO TRY AND CONTROL IT. EVEN WITH DR

I have just come back from a funeral for my brother. He was just 62. He was on statin medicine but his cholestrol, blood pressure, weight and diet was very much in control. In fact just a day before his death the doctor told him that he was doing f

Since taking Karvezide (2years after Karvea was proved to unsuccessfull in reducing my high blood pressusre) I have experienced a lot of problems with nasal drip and a permanent muscas build up in the throat. Nothing seems to relieve the problem.

When I reported to my doctor that i was frequently having to urinate he had a blood test carried out with the result that my prostrate was OK he prescribed Permixon 160 mg twice per day and Tamsulosina STADA 0,4 mg once per day. I am now urinating

can platelete count reduced drastically to 1000 on medication of sibelium 5 mg for 2 weeks.

WHITE BLOOD CELL COUNT DECREASED Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Comparison of Absorption of Vaginal Diazepam Using Different Delivery Systems
Condition: Metabolism, Drug
Interventions: Drug: Diazepam tablet, 5 mg, vaginal;   Drug: Diazepam Suppository, 5 mg, vaginal;   Drug: Diazepam Cream, 5 mg, Vaginal
Outcome Measures: Serum Diazepam levels measured over time;   Side effects observed with each of three types of vaginal Diazepam
2 Recruiting Vaginal Diazepam for the Treatment of Female Pelvic Pain
Conditions: Pelvic Floor Disorders;   Pelvic Pain
Interventions: Drug: Diazepam;   Drug: Placebo
Outcome Measures: Change from baseline in Visual Analog Pain Scale score at 4 weeks, 12 weeks, and 24 weeks.;   Change from baseline in Pelvic Floor Distress Inventory-20 Questionnaire score at 4 weeks, 12 weeks, and 24 weeks.;   Change from baseline in McGill Pain Questionnaire score at 4 weeks, 12 weeks, and 24 weeks.;   Change from baseline in Global Response Assessment score at 4 weeks, 12 weeks, and 24 weeks.
3 Recruiting Lofexidine for Inpatient Opiate Detox in Singapore
Condition: Opiate Dependent Patients Who Are Undergoing Inpatient Detoxification in Singapore
Interventions: Drug: Lofexidine;   Drug: Diazepam;   Drug: Placebo for Lofexidine;   Drug: Placebo for Diazepam
Outcome Measures: To evaluate differences in OOWS (Objective Opiate Withdrawal Scale);   To evaluate differences in SOWS (Short Opiate Withdrawal Scale);   To evaluate differences in pupil sizes;   To evaluate differences in craving on the Visual Analogue Scale;   To evaluate differences in time to drop-out (length of stay on the ward);   To evaluate differences in emotional/psychological symptoms
4 Unknown  Performance Study of the SOLO 2.0 Insulin Pump
Condition: Type 1 Diabetes
Intervention: Device: SOLO insulin pump
Outcome Measures: Device related safety issues;   SOLO use errors;   Device-related adverse outcome;   Diabetes-related adverse outcome;   Satisfaction iwth SOLO;   Product quality (MTBF)
5 Recruiting Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy
Condition: Pancreaticoduodenectomy (E04.210.760)
Interventions: Behavioral: Enhanced recovery after surgery protocol;   Procedure: Standard perioperative care;   Drug: PONV prophylaxis with Ondansetron + Dexamethasone;   Other: Postoperative mobilization program;   Drug: Epidural analgesia with naropin + sufentanil;   Drug: Pre-anesthetic medication with Diazepam;   Behavioral: Preadmission counselling;   Drug: Preoperative bowel preparation with sodium phosphate
Outcome Measures: Adherence to the pathway;   Postoperative outcome
6 Recruiting A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction
Condition: Post-operative Pain
Interventions: Drug: Bupivacaine;   Drug: Botulinum Toxins;   Drug: Analgesics
Outcome Measure: Pain Score Questionnaire
7 Recruiting Perioperative Δ9-THC for Postsurgical Pain
Condition: Pain
Interventions: Drug: Namisol;   Drug: Diazepam/placebo
Outcome Measures: Analgesic efficacy;   Incidence of persistent continuous or intermittent postsurgical abdominal pain
8 Unknown  The Effect of Prescription Medications in Marijuana Users
Condition: Marijuana Abuse
Intervention: Drug: bupropion, Diazepam, dronabinol, ramelteon (Investigational Drug)
Outcome Measures: marijuana withdrawal;   subjective effects of smoked marijuana;   cognitive performance
9 Recruiting The PROOF Study: The PICC Related Obstruction Of Flow Study
Condition: Patients Indicated for a PICC for Any Medical Condition
Interventions: Device: BioFlo™ Peripherally Inserted Central Catheter (PICC);   Device: Bard® Dual-Lumen PowerPICC SOLO2®
Outcome Measures: Incidence of catheter-related venous thrombosis as confirmed by diagnostic ultrasound;   Incidence of other catheter-related complications
10 Not yet recruiting Implementing Health Plan-Level Care Management for Solo & Small Practices
Conditions: Bipolar Disorder;   Depression
Interventions: Behavioral: Chronic Care Model for Mood Disorders;   Other: Educational Control
Outcome Measures: Quality of Life;   Reduced Mood Disorder Symptoms;   Improved Guideline-Concordant Care;   Reduced Hospitalizations;   Improved Work Productivity
11 Unknown  Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner and Stereo Navigator Biopsy Accessory for the Diagnosis of Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: PEM Breast Biopsy
Outcome Measures: Evidence that breast biopsy can be performed using PEM and Stereo Navigator software;   Evidence that breast biopsy can be performed in less clinical visits than if biopsy is performed using MRI, mammogram, and/or ultrasound
12 Unknown  Quality of Sleep in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Diazepam, melatonin
Outcome Measure:
13 Recruiting Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability
Condition: Dental Care for Disabled
Interventions: Drug: Midazolam Mylan;   Drug: Lorazepam Mylan;   Drug: Valium + Akineton + Dehydrobenzperidol + Atropine sulfate
Outcome Measures: Level of cooperation of patient when receiving regular dental care;   Recording of vital parameters during regular dental care delivery;   Level of patient comfort and possible side-effects after dental treatment session
14 Recruiting Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer
Condition: Early Stage Breast Carcinoma
Interventions: Device: implanted port for chemo administration (X-port isp);   Device: Use of a PICC line for chemo administration (PowerPICC SOLO²)
Outcome Measures: Probability of occurrence of a significant adverse event related to the central venous device;   Patients' satisfaction for the use of their central venous device
15 Unknown  Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
Condition: Depression
Interventions: Device: Thrymatron System IV device (CONSOLIDATION ELECTROCONVUsLIVE THERAPY) plus PHARMACOTHERAPY;   Drug: PHARMACOTHERAPY
Outcome Measures: Hamilton Depression Rating Scale 21 items (HDRS-21);   Mini-Mental State Examination (MMSE 35);   UKU - Adverse effects rating scales;   Demographical Data Memory (MEDABI-20);   Rey Figure;   Trail Making Test A;   Trail Making Test B;   Stroop Test;   Direct and inverse digits (WAIS, Weschler Adults Intelligence Sacle).;   Vocabulary WAIS (Weschler Adults Intelligence Scale);   Frequency Hospitalization Quotient;   Hospital Day Quotient (HDQ)
16 Recruiting RCT of Mesh Versus Jet Nebulizers on Clinical Outcomes During Mechanical Ventilation in the Intensive Care Unit
Condition: Respiratory Insufficiency
Interventions: Device: Vibrating Mesh Nebulizer Arm;   Device: Jet Nebulizer Arm
Outcome Measures: Venilator Associated Events;   Bacterial Count and type;   Length of Stay in Intensive Care Unit;   Days on Mechanical Ventilation;   Ventilator-Associated Tracheobronchitis
17 Recruiting Gabapentin Treatment of Benzodiazepine Dependence
Condition: Benzodiazepine Dependence
Interventions: Drug: gabapentin;   Drug: Placebo
Outcome Measure: Abstinence from Benzodiazepine use
18 Recruiting Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment
Condition: Electrical Status Epilepticus in Sleep
Intervention: Drug: ESES treated with clobazam
Outcome Measures: Cognitive ability;   Language;   Executive function;   Adaptive/development skills;   Behavior;   Interictal epileptiform activity
19 Recruiting Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Condition: Febrile Seizure
Interventions: Drug: Carbogen;   Drug: Placebo
Outcome Measures: number of patients which need Diazepam;   number of severe adverse events;   manageability of the application assessed by the parents;   changes in quality of life of the parents and children after use of study medication;   contentment and anxiety of the parents
20 Unknown  Extended-release Epidural Morphine for Acute Post-operative Analgesia Following Selective Dorsal Rhizotomy in Children
Condition: Spastic Cerebral Palsy
Interventions: Drug: Extended-release Epidural morphine (EREM) 80;   Drug: Extended-release Epidural Morphine (EREM) 120;   Drug: Control: Saline
Outcome Measures: Quantity of fentanyl administered;   Adequacy of analgesia as judged by age-adjusted pain scales.;   Incidence of respiratory depression;   Hemodynamic instability;   Rate of CSF leak;   Rate of infection;   Urinary retention;   Nausea and/or vomiting;   Pruritis